Comparing antibiotic infusion methods for children with sepsis
Part of Infections clinical trials.
This study compares two ways of giving antibiotics to children with sepsis: the usual short infusions versus longer or continuous infusions. The goal is to see if one approach works better or is safer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 0 and 17 years old.
- Your child is in the pediatric or neonatal intensive care unit (PICU or NICU).
- Your child has been diagnosed with sepsis (a severe infection) that is confirmed or likely.
- Your child is receiving one of these antibiotics: meropenem, piperacillin/tazobactam, cefepime, or ceftriaxone.
- Your child has been on the same antibiotic for less than 24 hours or is starting a new one due to worsening condition.
- You (parent or guardian) give written consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways of giving a strong antibiotic (meropenem) to ICU patients with pneumonia and sepsis. It aims to see if giving the drug continuously or in shorter intervals works better. This could help clear the infection faster and improve recovery.
This trial compares two common antibiotics, meropenem and piperacillin/tazobactam, to see which works better for adults with sepsis who are critically ill. It aims to help doctors choose the best treatment for serious infections.
This study tests whether children can safely receive antibiotics continuously through a pump at home instead of in the hospital. The goal is to help children recover while staying with their family and avoiding prolonged hospital stays.
This study watches how safely two common antibiotics (vancomycin and a combination called piperacillin/tazobactam) work together in hospitalized patients with serious infections. Researchers want to make sure the combination doesn't harm kidney function.
This trial checks if giving higher doses of beta-lactam antibiotics (a type of strong antibiotic) right from the start helps people in the ICU with septic shock. It aims to find the best dose to fight the infection quickly.
This study tests whether giving an early antibiotic (meropenem) based on a new blood test (PSP) can prevent serious infections (sepsis) in people who come to the emergency department with signs of infection. The goal is to find out if this approach helps them get better faster and avoid more severe illness.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.